Novo Nordisk Investigational Site

Box Hill, Victoria 3128

0 studies enrolling now · 7 studies all time

What they study most

Adult Growth Hormone Deficiency, Asthma, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Growth Hormone Disorder, Hepatobiliary Disorders, Non-alcoholic Steatohepatitis

Studies at this site

• Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis. — Completed
• Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. — Completed
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results — Completed
• Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes — Completed
• The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy — Completed
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma — Stopped early
• Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes — Completed